These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 10752973)

  • 1. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.
    Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
    Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of SEER-Medicare data for measuring cancer surgery.
    Cooper GS; Virnig B; Klabunde CN; Schussler N; Freeman J; Warren JL
    Med Care; 2002 Aug; 40(8 Suppl):IV-43-8. PubMed ID: 12187167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of Medicare claims data for measuring cancer stage.
    Cooper GS; Yuan Z; Stange KC; Amini SB; Dennis LK; Rimm AA
    Med Care; 1999 Jul; 37(7):706-11. PubMed ID: 10424641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construct validity of medicare chemotherapy claims: the case of 5FU.
    Lamont EB; Lauderdale DS; Schilsky RL; Christakis NA
    Med Care; 2002 Mar; 40(3):201-11. PubMed ID: 11880793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying radiation therapy using SEER-Medicare-linked data.
    Virnig BA; Warren JL; Cooper GS; Klabunde CN; Schussler N; Freeman J
    Med Care; 2002 Aug; 40(8 Suppl):IV-49-54. PubMed ID: 12187168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
    Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
    Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
    Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
    Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis date agreement between SEER and Medicare claims data: impact on treatment.
    Lin CC; Virgo KS
    Med Care; 2014 Jan; 52(1):32-7. PubMed ID: 24322987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.
    Onukwugha E; Yong C; Hussain A; Seal B; Mullins CD
    BMC Med Res Methodol; 2014 Jan; 14():1. PubMed ID: 24383436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer.
    Du X; Freeman JL; Warren JL; Nattinger AB; Zhang D; Goodwin JS
    Med Care; 2000 Jul; 38(7):719-27. PubMed ID: 10901355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An algorithm for the use of Medicare claims data to identify women with incident breast cancer.
    Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL
    Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of breast conserving surgery: linking insurance claims with tumor registry data.
    Maskarinec G; Dhakal S; Yamashiro G; Issell BF
    BMC Cancer; 2002; 2():3. PubMed ID: 11879527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of SEER Treatment Data With Medicare Claims.
    Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL
    Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying Cancer-Directed Surgeries in Medicare Claims: A Validation Study Using SEER-Medicare Data.
    Lavery JA; Lipitz-Snyderman A; Li DG; Bach PB; Panageas KS
    JCO Clin Cancer Inform; 2019 Feb; 3():1-24. PubMed ID: 30715928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
    Gold HT; Do HT
    Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment patterns for prostate cancer: comparison of Medicare claims data to medical record review.
    Fleming ST; Hamilton AS; Sabatino SA; Kimmick GG; Wu XC; Owen JB; Huang B; Hwang W;
    Med Care; 2014 Sep; 52(9):e58-64. PubMed ID: 23222532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of administrative claims to identify incident cases of lung cancer: a comparison of 3 health plans.
    Ramsey SD; Scoggins JF; Blough DK; McDermott CL; Reyes CM
    J Manag Care Pharm; 2009 Oct; 15(8):659-68. PubMed ID: 19803555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s.
    Kim SP; Feinglass J; Bennett CL; Lyons T; Simon C; Weinberg MN; Talamonti MS
    Cancer Invest; 2004; 22(2):225-33. PubMed ID: 15199605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Place of Death of Individuals with Terminal Cancer: New Insights from Medicare Hospice Place-of-Service Codes.
    Jarosek SL; Shippee TP; Virnig BA
    J Am Geriatr Soc; 2016 Sep; 64(9):1815-22. PubMed ID: 27534517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database.
    Wang K; Sheets NC; Basak R; Chen RC
    Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.